ACTR-62. A PHASE II STUDY OF TUMOR TREATING FIELDS (TTFIELDS) WITH TEMOZOLOMIDE IN PATIENTS WITH LOW-GRADE GLIOMAS

Approximately 2,000 to 3,000 adults are diagnosed with low-grade gliomas (LGGs) annually in the United States, with a median overall survival ranging from 3–9 years. Radiation and chemotherapy are used to treat LGGs but can increase the risk of transformation to high-grade tumors (HGG) and cause cog...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Juarez, Tiffany, Boucher, Najee, Heng, Annie, Gill, Jaya, Nguyen, Minhdan, Truong, Judy, Saria, Marlon, Achrol, Achal, Barkhoudarian, Garni, Kelly, Daniel, Kesari, Santosh
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2017
Soggetti:
Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692887/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.051
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi